Negative feelings (Discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk

American Journal of Hypertension

Volumn 9, Issue 6, 1996, Pages 545-550

  Agewall, Stefan ^a   Wikstrand, John ^b   Dahlöf, Carl ^b   Fagerberg, Björn ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Atherosclerosis; Cardiovascular disease; Discontent; Hypertension; Intima media thickness; Psychosocial symptoms; Quality of life

Indexed keywords

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; WELLBEING;

EID: 0030175530     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00355-X     Document Type: Article

References (25)

1. 1. Siegrist J, Peter R, Georg W, et al: Psychosocial and biobehavioral characteristics of hypertensive men with elevated atherogenic lipids. Atherosclerosis 1991;86: 211-218.
2. 2. Jenkins CD: Recent evidence supporting psychological and social risk factors for coronary disease (first of two parts). N Engl J Med 1976;294:987-994.
3. 3. Ruberman W, Weinblatt E, Goldberg JD, et al: Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1984;311:552-559.
4. 4. Matsumoto Y, Uyama O, Shimizu S, et al: Do anger and agression affect carotid atherosclerosis? Stroke 1993;24:983-986.
5. 5. Welin L, Tibblin G, Svärdsudd K, et al: Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet 1985;i:915-918.
6. 6. Kaplan JR, Manuck SB, Clarkson TB, et al: Social stress and atherosclerosis in normocholesterolemic monkeys. Science 1983;220:733-735.
7. 7. Persson B, Andersson OK, Hjemdahl P, et al: Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. J Hypertens 1989;7:747-756.
8. 8. Lanza F, Beretz A, Stierlé A, et al: Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 1988;255:H1276-H1288.
9. 9. Hayano J, Sakakibara Y, Yamada M, et al: Decreased magnitude of heart rate spectral components in coronary heart disease: its relation to angiographic severity. Circulation 1990;81:1217-1224.
10. 10. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-838.
11. 11. Samuelsson O: Hypertension in middle-aged men: management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand 1985; (suppl 702):1-79.
12. 12. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-174.
13. 13. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 men. Arch Intern Med 1992;152:56-64.
14. 14. Suurküla M, Agewall S, Fagerberg B, et al: Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Arterioscler Thromb 1994;14:1297-1304.
15. 15. Wendelhag I, Wiklund O, Wikstrand J: Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb 1992;12:70-77.
16. 16. Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(suppl II):II56-II65.
17. 17. Dahlöf C, Dimenäs E, Olofsson B: Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy. Cardiovasc Drug Ther 1989;3:919-927.
18. 18. Dahlöf C: Minor symptoms evaluation (MSE) profile -a questionnaire for assessment of subjective CNS-related symptoms. Scand J Prim Health Care 1990;(suppl 1):19-25.
19. 19. Dimenäs E, Wiklund I, Dahlöf C, et al: Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives. J Hypertens 1989;7:885-890.
20. 20. Agewall S, Samuelsson O, Andersson OK, et al: The efficacy of multiple risk factor intervention in treated hypertensive men, during long term follow-up. J Int Med 1994;236:651-659.
21. 21. WHO Expert Committee on Diabetes Mellitus: Technical Report Series No 646. World Health Organization, Geneva, 1980.
22. 22. Wilhelmsen L, Berglund G, Elmfeldt D, et al: The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986;7:279-288.
23. 23. Henry JP, Ely DL, Stephens PM, et al: The role of psychosocial factors in the development of atherosclerosis in CBA mice: observations on the heart, kidney and aorta. Atherosclerosis 1971;14:203-218.
24. 24. Kaplan JR, Manuck SB, Clarkson TB, et al: Animal models of behavioral influences on atherogenesis. Adv Behav Med 1985;1:115-163.
25. 25. The Review Panel on Coronary-Prone Behaviour and Coronary Heart Disease: Coronary-prone behaviour and coronary heart disease. Circulation 1981;63:1199-1215.